Cardinal Health (CAH)
(Delayed Data from NYSE)
$98.18 USD
-0.17 (-0.17%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $98.22 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
- YR Estimate
- 06/30/2023
- 06/30/2022
- 06/30/2021
- 06/30/2020
- 06/30/2019
- Revenue - Line of Business (LOBR)
- Revenue: Pharmaceutical
- 190,009.00
- 165,491.00
- 145,796.00
- 137,495.00
- 129,917.00
- Revenue - Line of Business (LOBR)
- Revenue: Medical
- 15,014.00
- 15,887.00
- 16,687.00
- 15,444.00
- 15,633.00
- Revenue - Line of Business (LOBR)
- Revenue: Corporate
- -11.00
- -14.00
- -16.00
- -17.00
- -16.00
- Revenue - Line of Business (LOBR)
- Pharmaceutical Segment Revenue: Nuclear and Precision Health Solutions
- 1,197.00
- 911.00
- 808.00
- 802.00
- --
- Revenue - Line of Business (LOBR)
- Medical Segment Revenue: Medical Products and Distribution
- 12,374.00
- 13,462.00
- 14,485.00
- 13,429.00
- --
- Revenue - Line of Business (LOBR)
- Medical Segment Revenue: Cardinal Health at-Home Solutions
- 2,640.00
- 2,425.00
- 2,202.00
- 2,015.00
- --
- Revenue - Geographic (GEOR)
- Geographic Revenue: United States
- 200,384.00
- 176,855.00
- 157,756.00
- 148,707.00
- 141,479.00
- Revenue - Geographic (GEOR)
- Geographic Revenue: International
- 4,639.00
- 4,523.00
- 4,727.00
- 4,232.00
- 4,071.00
- Income - Line of Business (LOBI)
- Segment profit: Pharmaceutical
- 1,999.00
- 1,770.00
- 1,684.00
- 1,753.00
- 1,834.00
- Income - Line of Business (LOBI)
- Segment profit: Medical
- 111.00
- 216.00
- 577.00
- 663.00
- 576.00
- Income - Line of Business (LOBI)
- Segment profit: Corporate
- -1,383.00
- -2,582.00
- -1,789.00
- -6,514.00
- -350.00